SCHEMBL26422705

SCHEMBL26422705

Cc1cc2c(Cl)cccn2c1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 8/20 0.38
ALDH1A1 P00352 7/20 0.38
NPC1 O15118 6/20 0.36
RAB9A P51151 6/20 0.36
PKM P14618 2/20 0.36
GRM5 P41594 5/20 0.36
HPGD P15428 4/20 0.35
MAPT P10636 3/20 0.35
NPSR1 Q6W5P4 2/20 0.35
L3MBTL1 Q9Y468 1/20 0.35
GAA P10253 2/20 0.34
PDE10A Q9Y233 1/20 0.34
NFKB1 P19838 1/20 0.34
NFKB2 Q00653 1/20 0.34
RELA Q04206 1/20 0.34
PTPN1 P18031 1/20 0.34
MAT2A P31153 1/20 0.32
SMN1; SMN2 Q16637 2/20 0.32
TP53 P04637 1/20 0.32
TSHR P16473 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7167679 0.79 ALDH1A1 (0.56) KDM4EALDH1A1NPC1RAB9APKM
SCHEMBL23385228 0.76 ALDH1A1 (0.38) KDM4EALDH1A1NPC1RAB9AGRM5
SCHEMBL26422702 0.76 ALDH1A1 (0.45) KDM4EALDH1A1NPC1RAB9AGRM5
SCHEMBL16632648 0.76 ALDH1A1 (0.38) KDM4EALDH1A1NPC1RAB9AGRM5
SCHEMBL16644707 0.76 GRM5 (0.38) KDM4EALDH1A1NPC1RAB9APKM
SCHEMBL26262466 0.76 GRM5 (0.34) KDM4EALDH1A1NPC1RAB9APKM
SCHEMBL7170576 0.75 ALDH1A1 (0.43) KDM4EALDH1A1NPC1RAB9APKM
SCHEMBL26422707 0.72 ALDH1A1 (0.38) KDM4EALDH1A1NPC1RAB9AGRM5
SCHEMBL22615195 0.71 ALDH1A1 (0.40) KDM4EALDH1A1NPC1RAB9AHPGD
SCHEMBL22615128 0.70 ALDH1A1 (0.41) KDM4EALDH1A1NPC1RAB9APKM

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230312481-A1 SUBSTITUTED (PHTHALAZIN-1-YLMETHYL)UREAS, SUBSTITUTED N-(PHTHALAZIN-1-YLMETHYL)AMIDES, AND ANALOGUES THEREOF ARBUTUS BIOPHARMA CORP (CA) 2023-10-05 US disclosed
US-20230312481-A1 SUBSTITUTED (PHTHALAZIN-1-YLMETHYL)UREAS, SUBSTITUTED N-(PHTHALAZIN-1-YLMETHYL)AMIDES, AND ANALOGUES THEREOF ARBUTUS BIOPHARMA CORP (CA) 2023-10-05 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230312481-A1 SUBSTITUTED (PHTHALAZIN-1-YLMETHYL)UREAS, SUBSTITUTED N-(PHTHALAZIN-1-YLMETHYL)AMIDES, AND ANALOGUES THEREOF NSD3, PML, NSD1 KDM4E 133/4885ALDH1A1 3447/4885NPC1 910/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.